Luigi Xerri, PhD

Dr. Xerri is Founder, Senior Strategic Advisor and Head of Scientific Affairs at VenatoRx Pharmaceuticals. He was co-founder and Chief Scientific Officer of Protez Pharmaceuticals and was previously Director of Antimicrobial Disease Strategy at GlaxoSmithKline. He had responsibility for the appropriate risk assessment of the portfolio, aligning discovery with Business Development, and to fill gaps via in-licensing. During his 36 year career in antibacterials, he has led or been part of international teams for the pre-clinical and clinical development of cephalosporins (cefuroxime and ceftazidime), carbapenems (Sanfetrinem and Razupenem) and quinolones (ofloxacin, levofloxacin and grepafloxacin) and made key contributions to their commercialization strategies. Dr. Xerri holds a Laurea in Biology and Microbiology from the University of Bologna, Italy.

Luigi Xerri, PhD is the Founder, Senior Strategic Advisor and Head of Scientific Affairs at Venatorx Pharmaceuticals, based in United States, North America. With a background in Health Care, Luigi Xerri, PhD has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.